State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, and Chemical Biology Center, Peking University, Beijing 100191, China.
ACS Appl Mater Interfaces. 2023 Feb 15;15(6):7713-7724. doi: 10.1021/acsami.2c18601. Epub 2023 Feb 2.
Despite hypersialylation of cancer cells together with a significant upregulation of sialyltransferase (ST) activity contributes to the metastatic cascade at multiple levels, there are few dedicated tools to interfere with their expression. Although transition state-based ST inhibitors are well-established, they are not membrane permeable. To tackle this problem, herein, we design and construct long-circulating, self-assembled core-shell nanoscale coordination polymer (NCP) nanoparticles carrying a transition state-based ST inhibitor, which make the inhibitor transmembrane and potently strip diverse sialoglycans from various cancer cells. In the experimental lung metastasis and metastasis prevention models, the nanoparticle device (NCP/STI) significantly inhibits metastases formation without systemic toxicity. This strategy enables ST inhibitors to be applied to cells and animals by providing them with a well-designed nanodelivery system. Our work opens a new avenue to the development of transition state-based ST inhibitors and demonstrates that NCP/STI holds great promise in achieving metastases inhibition for multiple cancers.
尽管癌细胞的高唾液酸化以及唾液酸转移酶(ST)活性的显著上调共同促进了转移级联反应的多个层面,但目前针对其表达的专门干预手段还很少。虽然基于过渡态的 ST 抑制剂已经得到很好的建立,但它们不能穿透细胞膜。为了解决这个问题,我们设计并构建了一种具有长循环、自组装核壳纳米级配位聚合物(NCP)纳米粒子的抑制剂,该抑制剂携带基于过渡态的 ST 抑制剂,使抑制剂能够穿透细胞膜,并从各种癌细胞中有效去除各种唾液糖蛋白。在实验性肺转移和转移预防模型中,纳米颗粒装置(NCP/STI)显著抑制转移形成,而没有全身毒性。该策略通过为 ST 抑制剂提供精心设计的纳米递药系统,使它们能够应用于细胞和动物。我们的工作为基于过渡态的 ST 抑制剂的开发开辟了新途径,并表明 NCP/STI 在抑制多种癌症的转移方面具有巨大的潜力。